Cargando…
The Value of Progression-Free Survival in Metastatic Breast Cancer: Results From a Survey of Patients and Providers
Background. Value assessments and treatment decision making typically focus on clinical endpoints, especially overall survival (OS). However, OS data are not always available, and surrogate markers may also have some value to patients. This study sought to estimate preferences for progression-free s...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589981/ https://www.ncbi.nlm.nih.gov/pubmed/31259249 http://dx.doi.org/10.1177/2381468319855386 |